nodes	percent_of_prediction	percent_of_DWPC	metapath
Pravastatin—CYP2C9—brain cancer	0.46	1	CbGaD
Pravastatin—CYP2D6—Lomustine—brain cancer	0.0456	0.131	CbGbCtD
Pravastatin—ABCC2—Carboplatin—brain cancer	0.0427	0.123	CbGbCtD
Pravastatin—ABCG2—Carboplatin—brain cancer	0.0386	0.111	CbGbCtD
Pravastatin—ABCC2—Etoposide—brain cancer	0.0359	0.103	CbGbCtD
Pravastatin—CYP2D6—Hydroxyurea—brain cancer	0.0346	0.0996	CbGbCtD
Pravastatin—CYP3A4—Temozolomide—brain cancer	0.0341	0.0983	CbGbCtD
Pravastatin—ABCG2—Etoposide—brain cancer	0.0324	0.0935	CbGbCtD
Pravastatin—CYP3A4—Lomustine—brain cancer	0.029	0.0836	CbGbCtD
Pravastatin—CYP3A5—Etoposide—brain cancer	0.018	0.0518	CbGbCtD
Pravastatin—CYP2C8—Etoposide—brain cancer	0.0173	0.0498	CbGbCtD
Pravastatin—ABCB1—Etoposide—brain cancer	0.0117	0.0337	CbGbCtD
Pravastatin—SLC22A8—choroid plexus—brain cancer	0.00726	0.191	CbGeAlD
Pravastatin—CYP3A4—Etoposide—brain cancer	0.00701	0.0202	CbGbCtD
Pravastatin—Simvastatin—CYP2C9—brain cancer	0.00217	0.505	CrCbGaD
Pravastatin—Lovastatin—CYP2C9—brain cancer	0.00212	0.495	CrCbGaD
Pravastatin—SLCO2B1—ganglion—brain cancer	0.00151	0.0396	CbGeAlD
Pravastatin—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00098	0.0405	CbGpPWpGaD
Pravastatin—SLCO1B3—pituitary gland—brain cancer	0.000925	0.0243	CbGeAlD
Pravastatin—SLC16A1—Pyruvate metabolism—BSG—brain cancer	0.000916	0.0379	CbGpPWpGaD
Pravastatin—SLC16A1—Basigin interactions—BSG—brain cancer	0.000887	0.0367	CbGpPWpGaD
Pravastatin—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00088	0.0364	CbGpPWpGaD
Pravastatin—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000801	0.0332	CbGpPWpGaD
Pravastatin—SLCO1B3—endocrine gland—brain cancer	0.000717	0.0189	CbGeAlD
Pravastatin—HMGCR—telencephalon—brain cancer	0.000686	0.0181	CbGeAlD
Pravastatin—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.000682	0.0282	CbGpPWpGaD
Pravastatin—SLC16A1—telencephalon—brain cancer	0.000676	0.0178	CbGeAlD
Pravastatin—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000675	0.0279	CbGpPWpGaD
Pravastatin—HMGCR—SREBF and miR33 in cholesterol and lipid homeostasis—SIRT1—brain cancer	0.000635	0.0263	CbGpPWpGaD
Pravastatin—ABCB11—endocrine gland—brain cancer	0.000618	0.0163	CbGeAlD
Pravastatin—SLCO2B1—telencephalon—brain cancer	0.000581	0.0153	CbGeAlD
Pravastatin—HMGCR—gonad—brain cancer	0.000573	0.0151	CbGeAlD
Pravastatin—SLC22A11—endocrine gland—brain cancer	0.000571	0.015	CbGeAlD
Pravastatin—SLC16A1—gonad—brain cancer	0.000564	0.0148	CbGeAlD
Pravastatin—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00056	0.0232	CbGpPWpGaD
Pravastatin—HMGCR—pituitary gland—brain cancer	0.000559	0.0147	CbGeAlD
Pravastatin—HMGCR—AMPK Signaling—STRADA—brain cancer	0.000559	0.0231	CbGpPWpGaD
Pravastatin—SLC22A7—endocrine gland—brain cancer	0.000557	0.0147	CbGeAlD
Pravastatin—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—BSG—brain cancer	0.000554	0.0229	CbGpPWpGaD
Pravastatin—SLC16A1—pituitary gland—brain cancer	0.00055	0.0145	CbGeAlD
Pravastatin—HMGCR—medulla oblongata—brain cancer	0.000539	0.0142	CbGeAlD
Pravastatin—ABCC2—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000538	0.0223	CbGpPWpGaD
Pravastatin—SLCO1A2—telencephalon—brain cancer	0.000535	0.0141	CbGeAlD
Pravastatin—SLC16A1—medulla oblongata—brain cancer	0.000531	0.014	CbGeAlD
Pravastatin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000513	0.0212	CbGpPWpGaD
Pravastatin—HMGCR—midbrain—brain cancer	0.000493	0.013	CbGeAlD
Pravastatin—CYP2D6—hindbrain—brain cancer	0.00049	0.0129	CbGeAlD
Pravastatin—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000488	0.0202	CbGpPWpGaD
Pravastatin—SLC16A1—midbrain—brain cancer	0.000485	0.0128	CbGeAlD
Pravastatin—HMGCR—spinal cord—brain cancer	0.000481	0.0126	CbGeAlD
Pravastatin—SLC16A1—spinal cord—brain cancer	0.000473	0.0125	CbGeAlD
Pravastatin—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.00047	0.0194	CbGpPWpGaD
Pravastatin—Neuropathy—Etoposide—brain cancer	0.000463	0.00367	CcSEcCtD
Pravastatin—Diplopia—Carmustine—brain cancer	0.000463	0.00367	CcSEcCtD
Pravastatin—Dysuria—Hydroxyurea—brain cancer	0.000463	0.00366	CcSEcCtD
Pravastatin—Chills—Procarbazine—brain cancer	0.00046	0.00364	CcSEcCtD
Pravastatin—Arrhythmia—Procarbazine—brain cancer	0.000458	0.00362	CcSEcCtD
Pravastatin—SLCO2B1—medulla oblongata—brain cancer	0.000457	0.012	CbGeAlD
Pravastatin—Body temperature increased—Lomustine—brain cancer	0.000453	0.00359	CcSEcCtD
Pravastatin—Alopecia—Procarbazine—brain cancer	0.000453	0.00358	CcSEcCtD
Pravastatin—Weight increased—Hydroxyurea—brain cancer	0.000451	0.00357	CcSEcCtD
Pravastatin—Diplopia—Temozolomide—brain cancer	0.000448	0.00354	CcSEcCtD
Pravastatin—Affect lability—Temozolomide—brain cancer	0.000441	0.00349	CcSEcCtD
Pravastatin—SLCO2B1—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000439	0.0182	CbGpPWpGaD
Pravastatin—Tension—Procarbazine—brain cancer	0.000438	0.00346	CcSEcCtD
Pravastatin—Nervousness—Procarbazine—brain cancer	0.000433	0.00343	CcSEcCtD
Pravastatin—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000433	0.00343	CcSEcCtD
Pravastatin—HMGCR—endocrine gland—brain cancer	0.000433	0.0114	CbGeAlD
Pravastatin—Liver function test abnormal—Carmustine—brain cancer	0.000428	0.00338	CcSEcCtD
Pravastatin—HMGCR—head—brain cancer	0.000427	0.0112	CbGeAlD
Pravastatin—SLC16A1—endocrine gland—brain cancer	0.000426	0.0112	CbGeAlD
Pravastatin—Mood swings—Temozolomide—brain cancer	0.000424	0.00336	CcSEcCtD
Pravastatin—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000423	0.0175	CbGpPWpGaD
Pravastatin—SLC16A1—head—brain cancer	0.000421	0.0111	CbGeAlD
Pravastatin—SLCO1A2—medulla oblongata—brain cancer	0.00042	0.0111	CbGeAlD
Pravastatin—Tremor—Procarbazine—brain cancer	0.000418	0.00331	CcSEcCtD
Pravastatin—SLCO1B1—endocrine gland—brain cancer	0.000415	0.0109	CbGeAlD
Pravastatin—Anaemia—Procarbazine—brain cancer	0.000412	0.00326	CcSEcCtD
Pravastatin—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.000412	0.00326	CcSEcCtD
Pravastatin—Dry skin—Temozolomide—brain cancer	0.00041	0.00325	CcSEcCtD
Pravastatin—Muscular weakness—Carmustine—brain cancer	0.000409	0.00323	CcSEcCtD
Pravastatin—SLCO2B1—spinal cord—brain cancer	0.000407	0.0107	CbGeAlD
Pravastatin—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000407	0.0168	CbGpPWpGaD
Pravastatin—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000403	0.00319	CcSEcCtD
Pravastatin—Leukopenia—Procarbazine—brain cancer	0.000399	0.00316	CcSEcCtD
Pravastatin—SLC22A7—brain—brain cancer	0.000399	0.0105	CbGeAlD
Pravastatin—Muscular weakness—Temozolomide—brain cancer	0.000395	0.00312	CcSEcCtD
Pravastatin—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000395	0.00312	CcSEcCtD
Pravastatin—HMGCR—central nervous system—brain cancer	0.00039	0.0103	CbGeAlD
Pravastatin—Abdominal distension—Temozolomide—brain cancer	0.00039	0.00308	CcSEcCtD
Pravastatin—Cough—Procarbazine—brain cancer	0.000389	0.00308	CcSEcCtD
Pravastatin—SLC22A6—brain—brain cancer	0.000385	0.0101	CbGeAlD
Pravastatin—Hypertension—Procarbazine—brain cancer	0.000385	0.00305	CcSEcCtD
Pravastatin—SLCO1A2—midbrain—brain cancer	0.000384	0.0101	CbGeAlD
Pravastatin—SLC16A1—central nervous system—brain cancer	0.000384	0.0101	CbGeAlD
Pravastatin—HMGCR—cerebellum—brain cancer	0.000381	0.01	CbGeAlD
Pravastatin—Arthralgia—Procarbazine—brain cancer	0.00038	0.003	CcSEcCtD
Pravastatin—Myalgia—Procarbazine—brain cancer	0.00038	0.003	CcSEcCtD
Pravastatin—Anxiety—Procarbazine—brain cancer	0.000378	0.00299	CcSEcCtD
Pravastatin—Sweating increased—Temozolomide—brain cancer	0.000377	0.00298	CcSEcCtD
Pravastatin—SLC16A1—cerebellum—brain cancer	0.000375	0.00988	CbGeAlD
Pravastatin—SLCO1A2—spinal cord—brain cancer	0.000375	0.00986	CbGeAlD
Pravastatin—ABCB1—blood vessel—brain cancer	0.000369	0.00972	CbGeAlD
Pravastatin—Confusional state—Procarbazine—brain cancer	0.000367	0.0029	CcSEcCtD
Pravastatin—SLCO2B1—endocrine gland—brain cancer	0.000367	0.00965	CbGeAlD
Pravastatin—Vomiting—Lomustine—brain cancer	0.000364	0.00288	CcSEcCtD
Pravastatin—Oedema—Procarbazine—brain cancer	0.000364	0.00288	CcSEcCtD
Pravastatin—ABCG2—telencephalon—brain cancer	0.000363	0.00956	CbGeAlD
Pravastatin—SLCO2B1—head—brain cancer	0.000362	0.00952	CbGeAlD
Pravastatin—Dysuria—Temozolomide—brain cancer	0.000362	0.00286	CcSEcCtD
Pravastatin—Infection—Procarbazine—brain cancer	0.000362	0.00286	CcSEcCtD
Pravastatin—Upper respiratory tract infection—Temozolomide—brain cancer	0.00036	0.00285	CcSEcCtD
Pravastatin—Erectile dysfunction—Temozolomide—brain cancer	0.000356	0.00282	CcSEcCtD
Pravastatin—Thrombocytopenia—Procarbazine—brain cancer	0.000356	0.00282	CcSEcCtD
Pravastatin—Depression—Carmustine—brain cancer	0.000356	0.00282	CcSEcCtD
Pravastatin—Chills—Hydroxyurea—brain cancer	0.000356	0.00281	CcSEcCtD
Pravastatin—Photosensitivity reaction—Temozolomide—brain cancer	0.000353	0.00279	CcSEcCtD
Pravastatin—Weight increased—Temozolomide—brain cancer	0.000352	0.00279	CcSEcCtD
Pravastatin—Hyperhidrosis—Procarbazine—brain cancer	0.000352	0.00278	CcSEcCtD
Pravastatin—Alopecia—Hydroxyurea—brain cancer	0.00035	0.00277	CcSEcCtD
Pravastatin—Weight decreased—Temozolomide—brain cancer	0.00035	0.00277	CcSEcCtD
Pravastatin—Neuropathy peripheral—Carmustine—brain cancer	0.00035	0.00277	CcSEcCtD
Pravastatin—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000347	0.0144	CbGpPWpGaD
Pravastatin—Urinary tract infection—Carmustine—brain cancer	0.000347	0.00275	CcSEcCtD
Pravastatin—Anorexia—Procarbazine—brain cancer	0.000347	0.00274	CcSEcCtD
Pravastatin—Depression—Temozolomide—brain cancer	0.000344	0.00272	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000342	0.00271	CcSEcCtD
Pravastatin—Nausea—Lomustine—brain cancer	0.00034	0.00269	CcSEcCtD
Pravastatin—Neuropathy peripheral—Temozolomide—brain cancer	0.000338	0.00268	CcSEcCtD
Pravastatin—SLCO1A2—endocrine gland—brain cancer	0.000337	0.00888	CbGeAlD
Pravastatin—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000335	0.0139	CbGpPWpGaD
Pravastatin—Urinary tract infection—Temozolomide—brain cancer	0.000335	0.00265	CcSEcCtD
Pravastatin—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000334	0.0138	CbGpPWpGaD
Pravastatin—SLCO1A2—head—brain cancer	0.000333	0.00876	CbGeAlD
Pravastatin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000332	0.00262	CcSEcCtD
Pravastatin—SLCO2B1—central nervous system—brain cancer	0.00033	0.00869	CbGeAlD
Pravastatin—Insomnia—Procarbazine—brain cancer	0.000329	0.0026	CcSEcCtD
Pravastatin—Paraesthesia—Procarbazine—brain cancer	0.000327	0.00259	CcSEcCtD
Pravastatin—Sinusitis—Temozolomide—brain cancer	0.000324	0.00256	CcSEcCtD
Pravastatin—SLCO2B1—cerebellum—brain cancer	0.000323	0.0085	CbGeAlD
Pravastatin—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000323	0.00255	CcSEcCtD
Pravastatin—Cramp muscle—Etoposide—brain cancer	0.000323	0.00255	CcSEcCtD
Pravastatin—ABCB11—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000323	0.0133	CbGpPWpGaD
Pravastatin—Ill-defined disorder—Hydroxyurea—brain cancer	0.00032	0.00253	CcSEcCtD
Pravastatin—Anaemia—Hydroxyurea—brain cancer	0.000319	0.00252	CcSEcCtD
Pravastatin—Hypoaesthesia—Carmustine—brain cancer	0.000319	0.00252	CcSEcCtD
Pravastatin—SLC22A8—head—brain cancer	0.000318	0.00837	CbGeAlD
Pravastatin—Decreased appetite—Procarbazine—brain cancer	0.000316	0.0025	CcSEcCtD
Pravastatin—Alanine aminotransferase increased—Etoposide—brain cancer	0.000316	0.0025	CcSEcCtD
Pravastatin—ABCC2—endocrine gland—brain cancer	0.000314	0.00827	CbGeAlD
Pravastatin—Fatigue—Procarbazine—brain cancer	0.000314	0.00248	CcSEcCtD
Pravastatin—Malaise—Hydroxyurea—brain cancer	0.000311	0.00246	CcSEcCtD
Pravastatin—Constipation—Procarbazine—brain cancer	0.000311	0.00246	CcSEcCtD
Pravastatin—Pain—Procarbazine—brain cancer	0.000311	0.00246	CcSEcCtD
Pravastatin—Hepatitis—Temozolomide—brain cancer	0.00031	0.00245	CcSEcCtD
Pravastatin—HMGCR—brain—brain cancer	0.00031	0.00815	CbGeAlD
Pravastatin—Leukopenia—Hydroxyurea—brain cancer	0.000309	0.00244	CcSEcCtD
Pravastatin—Visual impairment—Carmustine—brain cancer	0.000309	0.00244	CcSEcCtD
Pravastatin—Hypoaesthesia—Temozolomide—brain cancer	0.000308	0.00244	CcSEcCtD
Pravastatin—Pharyngitis—Temozolomide—brain cancer	0.000307	0.00243	CcSEcCtD
Pravastatin—SLC16A1—brain—brain cancer	0.000305	0.00802	CbGeAlD
Pravastatin—CYP2C8—pituitary gland—brain cancer	0.000304	0.00801	CbGeAlD
Pravastatin—SLCO1A2—central nervous system—brain cancer	0.000304	0.008	CbGeAlD
Pravastatin—Sweating increased—Etoposide—brain cancer	0.000302	0.00239	CcSEcCtD
Pravastatin—Feeling abnormal—Procarbazine—brain cancer	0.0003	0.00237	CcSEcCtD
Pravastatin—Visual impairment—Temozolomide—brain cancer	0.000298	0.00236	CcSEcCtD
Pravastatin—Gastrointestinal pain—Procarbazine—brain cancer	0.000298	0.00235	CcSEcCtD
Pravastatin—Flushing—Carmustine—brain cancer	0.000297	0.00235	CcSEcCtD
Pravastatin—SLCO1A2—cerebellum—brain cancer	0.000297	0.00782	CbGeAlD
Pravastatin—ABCG2—pituitary gland—brain cancer	0.000296	0.00778	CbGeAlD
Pravastatin—SLC16A1—Cell surface interactions at the vascular wall—BSG—brain cancer	0.000295	0.0122	CbGpPWpGaD
Pravastatin—Erythema multiforme—Temozolomide—brain cancer	0.000293	0.00232	CcSEcCtD
Pravastatin—SLC22A8—central nervous system—brain cancer	0.00029	0.00764	CbGeAlD
Pravastatin—Discomfort—Hydroxyurea—brain cancer	0.00029	0.0023	CcSEcCtD
Pravastatin—Urticaria—Procarbazine—brain cancer	0.000289	0.00229	CcSEcCtD
Pravastatin—Tinnitus—Temozolomide—brain cancer	0.000289	0.00228	CcSEcCtD
Pravastatin—Body temperature increased—Procarbazine—brain cancer	0.000288	0.00228	CcSEcCtD
Pravastatin—Abdominal pain—Procarbazine—brain cancer	0.000288	0.00228	CcSEcCtD
Pravastatin—Flushing—Temozolomide—brain cancer	0.000287	0.00227	CcSEcCtD
Pravastatin—Cardiac disorder—Temozolomide—brain cancer	0.000287	0.00227	CcSEcCtD
Pravastatin—Arrhythmia—Carmustine—brain cancer	0.000286	0.00227	CcSEcCtD
Pravastatin—ABCG2—medulla oblongata—brain cancer	0.000286	0.00751	CbGeAlD
Pravastatin—Alopecia—Carmustine—brain cancer	0.000283	0.00224	CcSEcCtD
Pravastatin—Oedema—Hydroxyurea—brain cancer	0.000282	0.00223	CcSEcCtD
Pravastatin—CYP2D6—brainstem—brain cancer	0.000281	0.00738	CbGeAlD
Pravastatin—Infection—Hydroxyurea—brain cancer	0.00028	0.00221	CcSEcCtD
Pravastatin—Chills—Temozolomide—brain cancer	0.000278	0.0022	CcSEcCtD
Pravastatin—ABCC2—Irinotecan Pathway—APC—brain cancer	0.000276	0.0114	CbGpPWpGaD
Pravastatin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000276	0.00218	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000274	0.00217	CcSEcCtD
Pravastatin—Alopecia—Temozolomide—brain cancer	0.000274	0.00217	CcSEcCtD
Pravastatin—Acute coronary syndrome—Etoposide—brain cancer	0.000272	0.00215	CcSEcCtD
Pravastatin—Neuropathy peripheral—Etoposide—brain cancer	0.000271	0.00214	CcSEcCtD
Pravastatin—Myocardial infarction—Etoposide—brain cancer	0.000271	0.00214	CcSEcCtD
Pravastatin—Jaundice—Etoposide—brain cancer	0.000269	0.00213	CcSEcCtD
Pravastatin—Anorexia—Hydroxyurea—brain cancer	0.000268	0.00212	CcSEcCtD
Pravastatin—Hypersensitivity—Procarbazine—brain cancer	0.000268	0.00212	CcSEcCtD
Pravastatin—Dysgeusia—Temozolomide—brain cancer	0.000264	0.00209	CcSEcCtD
Pravastatin—Vision blurred—Carmustine—brain cancer	0.000263	0.00208	CcSEcCtD
Pravastatin—SLCO2B1—brain—brain cancer	0.000262	0.0069	CbGeAlD
Pravastatin—Tremor—Carmustine—brain cancer	0.000261	0.00207	CcSEcCtD
Pravastatin—Asthenia—Procarbazine—brain cancer	0.000261	0.00207	CcSEcCtD
Pravastatin—ABCG2—midbrain—brain cancer	0.000261	0.00687	CbGeAlD
Pravastatin—SLCO1B1—Irinotecan Pathway—APC—brain cancer	0.00026	0.0107	CbGpPWpGaD
Pravastatin—Anaemia—Carmustine—brain cancer	0.000258	0.00204	CcSEcCtD
Pravastatin—Pruritus—Procarbazine—brain cancer	0.000257	0.00204	CcSEcCtD
Pravastatin—ABCG2—spinal cord—brain cancer	0.000255	0.0067	CbGeAlD
Pravastatin—Vision blurred—Temozolomide—brain cancer	0.000254	0.00201	CcSEcCtD
Pravastatin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000253	0.0105	CbGpPWpGaD
Pravastatin—Tremor—Temozolomide—brain cancer	0.000253	0.002	CcSEcCtD
Pravastatin—Dyspnoea—Hydroxyurea—brain cancer	0.000251	0.00199	CcSEcCtD
Pravastatin—Ill-defined disorder—Temozolomide—brain cancer	0.00025	0.00198	CcSEcCtD
Pravastatin—Leukopenia—Carmustine—brain cancer	0.00025	0.00198	CcSEcCtD
Pravastatin—Anaemia—Temozolomide—brain cancer	0.000249	0.00197	CcSEcCtD
Pravastatin—CYP2D6—telencephalon—brain cancer	0.000249	0.00655	CbGeAlD
Pravastatin—Diarrhoea—Procarbazine—brain cancer	0.000249	0.00197	CcSEcCtD
Pravastatin—Dyspepsia—Hydroxyurea—brain cancer	0.000248	0.00196	CcSEcCtD
Pravastatin—Hypoaesthesia—Etoposide—brain cancer	0.000247	0.00195	CcSEcCtD
Pravastatin—Angioedema—Temozolomide—brain cancer	0.000246	0.00195	CcSEcCtD
Pravastatin—Decreased appetite—Hydroxyurea—brain cancer	0.000245	0.00194	CcSEcCtD
Pravastatin—Malaise—Temozolomide—brain cancer	0.000243	0.00192	CcSEcCtD
Pravastatin—Fatigue—Hydroxyurea—brain cancer	0.000243	0.00192	CcSEcCtD
Pravastatin—Vertigo—Temozolomide—brain cancer	0.000242	0.00192	CcSEcCtD
Pravastatin—SLCO1A2—brain—brain cancer	0.000241	0.00635	CbGeAlD
Pravastatin—Leukopenia—Temozolomide—brain cancer	0.000241	0.00191	CcSEcCtD
Pravastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000241	0.00998	CbGpPWpGaD
Pravastatin—Hypertension—Carmustine—brain cancer	0.000241	0.00191	CcSEcCtD
Pravastatin—Constipation—Hydroxyurea—brain cancer	0.000241	0.00191	CcSEcCtD
Pravastatin—Pain—Hydroxyurea—brain cancer	0.000241	0.00191	CcSEcCtD
Pravastatin—Dizziness—Procarbazine—brain cancer	0.000241	0.0019	CcSEcCtD
Pravastatin—ABCG2—Irinotecan Pathway—APC—brain cancer	0.00024	0.00995	CbGpPWpGaD
Pravastatin—Myalgia—Carmustine—brain cancer	0.000238	0.00188	CcSEcCtD
Pravastatin—Chest pain—Carmustine—brain cancer	0.000238	0.00188	CcSEcCtD
Pravastatin—Anxiety—Carmustine—brain cancer	0.000237	0.00187	CcSEcCtD
Pravastatin—CYP2C8—endocrine gland—brain cancer	0.000236	0.0062	CbGeAlD
Pravastatin—Cough—Temozolomide—brain cancer	0.000235	0.00186	CcSEcCtD
Pravastatin—Erythema multiforme—Etoposide—brain cancer	0.000234	0.00185	CcSEcCtD
Pravastatin—Hypertension—Temozolomide—brain cancer	0.000233	0.00184	CcSEcCtD
Pravastatin—Feeling abnormal—Hydroxyurea—brain cancer	0.000232	0.00184	CcSEcCtD
Pravastatin—Vomiting—Procarbazine—brain cancer	0.000231	0.00183	CcSEcCtD
Pravastatin—SLC22A8—brain—brain cancer	0.00023	0.00606	CbGeAlD
Pravastatin—Cardiac disorder—Etoposide—brain cancer	0.00023	0.00182	CcSEcCtD
Pravastatin—Flushing—Etoposide—brain cancer	0.00023	0.00182	CcSEcCtD
Pravastatin—Confusional state—Carmustine—brain cancer	0.00023	0.00182	CcSEcCtD
Pravastatin—Arthralgia—Temozolomide—brain cancer	0.00023	0.00182	CcSEcCtD
Pravastatin—Myalgia—Temozolomide—brain cancer	0.00023	0.00182	CcSEcCtD
Pravastatin—Rash—Procarbazine—brain cancer	0.000229	0.00182	CcSEcCtD
Pravastatin—Dermatitis—Procarbazine—brain cancer	0.000229	0.00181	CcSEcCtD
Pravastatin—Anxiety—Temozolomide—brain cancer	0.000229	0.00181	CcSEcCtD
Pravastatin—Headache—Procarbazine—brain cancer	0.000228	0.0018	CcSEcCtD
Pravastatin—Oedema—Carmustine—brain cancer	0.000228	0.0018	CcSEcCtD
Pravastatin—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000227	0.0094	CbGpPWpGaD
Pravastatin—Discomfort—Temozolomide—brain cancer	0.000227	0.00179	CcSEcCtD
Pravastatin—Infection—Carmustine—brain cancer	0.000226	0.00179	CcSEcCtD
Pravastatin—Thrombocytopenia—Carmustine—brain cancer	0.000223	0.00176	CcSEcCtD
Pravastatin—Body temperature increased—Hydroxyurea—brain cancer	0.000223	0.00176	CcSEcCtD
Pravastatin—Chills—Etoposide—brain cancer	0.000222	0.00176	CcSEcCtD
Pravastatin—Confusional state—Temozolomide—brain cancer	0.000222	0.00176	CcSEcCtD
Pravastatin—Anaphylactic shock—Temozolomide—brain cancer	0.00022	0.00174	CcSEcCtD
Pravastatin—Oedema—Temozolomide—brain cancer	0.00022	0.00174	CcSEcCtD
Pravastatin—Alopecia—Etoposide—brain cancer	0.000219	0.00173	CcSEcCtD
Pravastatin—Infection—Temozolomide—brain cancer	0.000219	0.00173	CcSEcCtD
Pravastatin—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000218	0.00904	CbGpPWpGaD
Pravastatin—Anorexia—Carmustine—brain cancer	0.000217	0.00172	CcSEcCtD
Pravastatin—Nausea—Procarbazine—brain cancer	0.000216	0.00171	CcSEcCtD
Pravastatin—Thrombocytopenia—Temozolomide—brain cancer	0.000215	0.0017	CcSEcCtD
Pravastatin—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—BSG—brain cancer	0.000215	0.00889	CbGpPWpGaD
Pravastatin—CYP3A5—endocrine gland—brain cancer	0.000213	0.0056	CbGeAlD
Pravastatin—Hyperhidrosis—Temozolomide—brain cancer	0.000213	0.00168	CcSEcCtD
Pravastatin—Dysgeusia—Etoposide—brain cancer	0.000211	0.00167	CcSEcCtD
Pravastatin—Anorexia—Temozolomide—brain cancer	0.00021	0.00166	CcSEcCtD
Pravastatin—CYP2C9—endocrine gland—brain cancer	0.000209	0.00551	CbGeAlD
Pravastatin—Hypersensitivity—Hydroxyurea—brain cancer	0.000207	0.00164	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000207	0.00164	CcSEcCtD
Pravastatin—Muscle spasms—Etoposide—brain cancer	0.000207	0.00164	CcSEcCtD
Pravastatin—Insomnia—Carmustine—brain cancer	0.000206	0.00163	CcSEcCtD
Pravastatin—Paraesthesia—Carmustine—brain cancer	0.000204	0.00162	CcSEcCtD
Pravastatin—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000203	0.00841	CbGpPWpGaD
Pravastatin—Dyspnoea—Carmustine—brain cancer	0.000203	0.00161	CcSEcCtD
Pravastatin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000203	0.00839	CbGpPWpGaD
Pravastatin—Asthenia—Hydroxyurea—brain cancer	0.000202	0.0016	CcSEcCtD
Pravastatin—ABCG2—cerebellum—brain cancer	0.000202	0.00531	CbGeAlD
Pravastatin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.0002	0.00159	CcSEcCtD
Pravastatin—Ill-defined disorder—Etoposide—brain cancer	0.0002	0.00158	CcSEcCtD
Pravastatin—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.0002	0.00828	CbGpPWpGaD
Pravastatin—Anaemia—Etoposide—brain cancer	0.000199	0.00158	CcSEcCtD
Pravastatin—Insomnia—Temozolomide—brain cancer	0.000199	0.00157	CcSEcCtD
Pravastatin—Decreased appetite—Carmustine—brain cancer	0.000198	0.00157	CcSEcCtD
Pravastatin—Paraesthesia—Temozolomide—brain cancer	0.000198	0.00156	CcSEcCtD
Pravastatin—HMGCR—SREBP signalling—SIRT1—brain cancer	0.000197	0.00816	CbGpPWpGaD
Pravastatin—Dyspnoea—Temozolomide—brain cancer	0.000196	0.00155	CcSEcCtD
Pravastatin—Constipation—Carmustine—brain cancer	0.000195	0.00154	CcSEcCtD
Pravastatin—Pain—Carmustine—brain cancer	0.000195	0.00154	CcSEcCtD
Pravastatin—Malaise—Etoposide—brain cancer	0.000195	0.00154	CcSEcCtD
Pravastatin—Vertigo—Etoposide—brain cancer	0.000194	0.00153	CcSEcCtD
Pravastatin—Dyspepsia—Temozolomide—brain cancer	0.000194	0.00153	CcSEcCtD
Pravastatin—Leukopenia—Etoposide—brain cancer	0.000193	0.00153	CcSEcCtD
Pravastatin—Diarrhoea—Hydroxyurea—brain cancer	0.000193	0.00152	CcSEcCtD
Pravastatin—Decreased appetite—Temozolomide—brain cancer	0.000191	0.00151	CcSEcCtD
Pravastatin—Fatigue—Temozolomide—brain cancer	0.00019	0.0015	CcSEcCtD
Pravastatin—Cough—Etoposide—brain cancer	0.000188	0.00149	CcSEcCtD
Pravastatin—Constipation—Temozolomide—brain cancer	0.000188	0.00149	CcSEcCtD
Pravastatin—Pain—Temozolomide—brain cancer	0.000188	0.00149	CcSEcCtD
Pravastatin—Feeling abnormal—Carmustine—brain cancer	0.000188	0.00148	CcSEcCtD
Pravastatin—Hypertension—Etoposide—brain cancer	0.000186	0.00147	CcSEcCtD
Pravastatin—Dizziness—Hydroxyurea—brain cancer	0.000186	0.00147	CcSEcCtD
Pravastatin—Gastrointestinal pain—Carmustine—brain cancer	0.000186	0.00147	CcSEcCtD
Pravastatin—Chest pain—Etoposide—brain cancer	0.000184	0.00145	CcSEcCtD
Pravastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000182	0.00755	CbGpPWpGaD
Pravastatin—Discomfort—Etoposide—brain cancer	0.000181	0.00144	CcSEcCtD
Pravastatin—Feeling abnormal—Temozolomide—brain cancer	0.000181	0.00143	CcSEcCtD
Pravastatin—Body temperature increased—Carmustine—brain cancer	0.00018	0.00142	CcSEcCtD
Pravastatin—Abdominal pain—Carmustine—brain cancer	0.00018	0.00142	CcSEcCtD
Pravastatin—Gastrointestinal pain—Temozolomide—brain cancer	0.00018	0.00142	CcSEcCtD
Pravastatin—ABCB1—telencephalon—brain cancer	0.000179	0.00471	CbGeAlD
Pravastatin—Vomiting—Hydroxyurea—brain cancer	0.000179	0.00142	CcSEcCtD
Pravastatin—Rash—Hydroxyurea—brain cancer	0.000178	0.00141	CcSEcCtD
Pravastatin—Confusional state—Etoposide—brain cancer	0.000178	0.0014	CcSEcCtD
Pravastatin—Dermatitis—Hydroxyurea—brain cancer	0.000177	0.0014	CcSEcCtD
Pravastatin—Headache—Hydroxyurea—brain cancer	0.000176	0.0014	CcSEcCtD
Pravastatin—Anaphylactic shock—Etoposide—brain cancer	0.000176	0.00139	CcSEcCtD
Pravastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000176	0.00727	CbGpPWpGaD
Pravastatin—Infection—Etoposide—brain cancer	0.000175	0.00138	CcSEcCtD
Pravastatin—Urticaria—Temozolomide—brain cancer	0.000175	0.00138	CcSEcCtD
Pravastatin—Body temperature increased—Temozolomide—brain cancer	0.000174	0.00138	CcSEcCtD
Pravastatin—Abdominal pain—Temozolomide—brain cancer	0.000174	0.00138	CcSEcCtD
Pravastatin—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000173	0.00717	CbGpPWpGaD
Pravastatin—Thrombocytopenia—Etoposide—brain cancer	0.000172	0.00136	CcSEcCtD
Pravastatin—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000172	0.00713	CbGpPWpGaD
Pravastatin—Hyperhidrosis—Etoposide—brain cancer	0.00017	0.00135	CcSEcCtD
Pravastatin—CYP2C8—brain—brain cancer	0.000169	0.00444	CbGeAlD
Pravastatin—Anorexia—Etoposide—brain cancer	0.000168	0.00133	CcSEcCtD
Pravastatin—Hypersensitivity—Carmustine—brain cancer	0.000168	0.00133	CcSEcCtD
Pravastatin—Nausea—Hydroxyurea—brain cancer	0.000167	0.00132	CcSEcCtD
Pravastatin—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000166	0.00687	CbGpPWpGaD
Pravastatin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000164	0.0068	CbGpPWpGaD
Pravastatin—ABCG2—brain—brain cancer	0.000164	0.00431	CbGeAlD
Pravastatin—Asthenia—Carmustine—brain cancer	0.000163	0.00129	CcSEcCtD
Pravastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000163	0.00673	CbGpPWpGaD
Pravastatin—Hypersensitivity—Temozolomide—brain cancer	0.000162	0.00128	CcSEcCtD
Pravastatin—CYP3A4—endocrine gland—brain cancer	0.00016	0.0042	CbGeAlD
Pravastatin—Paraesthesia—Etoposide—brain cancer	0.000158	0.00125	CcSEcCtD
Pravastatin—Asthenia—Temozolomide—brain cancer	0.000158	0.00125	CcSEcCtD
Pravastatin—CYP2D6—endocrine gland—brain cancer	0.000157	0.00413	CbGeAlD
Pravastatin—Dyspnoea—Etoposide—brain cancer	0.000157	0.00124	CcSEcCtD
Pravastatin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000156	0.00645	CbGpPWpGaD
Pravastatin—Diarrhoea—Carmustine—brain cancer	0.000156	0.00123	CcSEcCtD
Pravastatin—Pruritus—Temozolomide—brain cancer	0.000156	0.00123	CcSEcCtD
Pravastatin—CYP2D6—head—brain cancer	0.000155	0.00408	CbGeAlD
Pravastatin—Decreased appetite—Etoposide—brain cancer	0.000153	0.00121	CcSEcCtD
Pravastatin—Fatigue—Etoposide—brain cancer	0.000152	0.0012	CcSEcCtD
Pravastatin—Dizziness—Carmustine—brain cancer	0.000151	0.00119	CcSEcCtD
Pravastatin—Pain—Etoposide—brain cancer	0.000151	0.00119	CcSEcCtD
Pravastatin—Constipation—Etoposide—brain cancer	0.000151	0.00119	CcSEcCtD
Pravastatin—Diarrhoea—Temozolomide—brain cancer	0.000151	0.00119	CcSEcCtD
Pravastatin—ABCB1—gonad—brain cancer	0.00015	0.00393	CbGeAlD
Pravastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000149	0.00615	CbGpPWpGaD
Pravastatin—ABCB1—pituitary gland—brain cancer	0.000146	0.00384	CbGeAlD
Pravastatin—Dizziness—Temozolomide—brain cancer	0.000145	0.00115	CcSEcCtD
Pravastatin—Feeling abnormal—Etoposide—brain cancer	0.000145	0.00115	CcSEcCtD
Pravastatin—Vomiting—Carmustine—brain cancer	0.000145	0.00115	CcSEcCtD
Pravastatin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000144	0.00597	CbGpPWpGaD
Pravastatin—Gastrointestinal pain—Etoposide—brain cancer	0.000144	0.00114	CcSEcCtD
Pravastatin—CYP3A4—central nervous system—brain cancer	0.000144	0.00379	CbGeAlD
Pravastatin—Rash—Carmustine—brain cancer	0.000144	0.00114	CcSEcCtD
Pravastatin—Dermatitis—Carmustine—brain cancer	0.000143	0.00113	CcSEcCtD
Pravastatin—Headache—Carmustine—brain cancer	0.000143	0.00113	CcSEcCtD
Pravastatin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000142	0.00589	CbGpPWpGaD
Pravastatin—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000142	0.00589	CbGpPWpGaD
Pravastatin—CYP2D6—central nervous system—brain cancer	0.000142	0.00373	CbGeAlD
Pravastatin—ABCB1—medulla oblongata—brain cancer	0.000141	0.0037	CbGeAlD
Pravastatin—HMGCR—AMPK Signaling—PIK3CG—brain cancer	0.00014	0.00581	CbGpPWpGaD
Pravastatin—Vomiting—Temozolomide—brain cancer	0.00014	0.00111	CcSEcCtD
Pravastatin—Urticaria—Etoposide—brain cancer	0.00014	0.00111	CcSEcCtD
Pravastatin—Body temperature increased—Etoposide—brain cancer	0.000139	0.0011	CcSEcCtD
Pravastatin—Abdominal pain—Etoposide—brain cancer	0.000139	0.0011	CcSEcCtD
Pravastatin—Rash—Temozolomide—brain cancer	0.000139	0.0011	CcSEcCtD
Pravastatin—Dermatitis—Temozolomide—brain cancer	0.000139	0.0011	CcSEcCtD
Pravastatin—CYP2D6—cerebellum—brain cancer	0.000138	0.00364	CbGeAlD
Pravastatin—Headache—Temozolomide—brain cancer	0.000138	0.00109	CcSEcCtD
Pravastatin—Nausea—Carmustine—brain cancer	0.000135	0.00107	CcSEcCtD
Pravastatin—Nausea—Temozolomide—brain cancer	0.000131	0.00103	CcSEcCtD
Pravastatin—Hypersensitivity—Etoposide—brain cancer	0.00013	0.00103	CcSEcCtD
Pravastatin—ABCB1—midbrain—brain cancer	0.000129	0.00339	CbGeAlD
Pravastatin—Asthenia—Etoposide—brain cancer	0.000126	0.001	CcSEcCtD
Pravastatin—ABCB1—spinal cord—brain cancer	0.000126	0.0033	CbGeAlD
Pravastatin—Pruritus—Etoposide—brain cancer	0.000125	0.000986	CcSEcCtD
Pravastatin—Diarrhoea—Etoposide—brain cancer	0.00012	0.000953	CcSEcCtD
Pravastatin—SLC16A1—Hemostasis—MPL—brain cancer	0.000118	0.0049	CbGpPWpGaD
Pravastatin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000117	0.00484	CbGpPWpGaD
Pravastatin—Dizziness—Etoposide—brain cancer	0.000116	0.000921	CcSEcCtD
Pravastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000114	0.00471	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—S100A10—brain cancer	0.000113	0.0047	CbGpPWpGaD
Pravastatin—ABCB1—endocrine gland—brain cancer	0.000113	0.00297	CbGeAlD
Pravastatin—CYP2D6—brain—brain cancer	0.000112	0.00296	CbGeAlD
Pravastatin—Vomiting—Etoposide—brain cancer	0.000112	0.000886	CcSEcCtD
Pravastatin—ABCB1—head—brain cancer	0.000112	0.00294	CbGeAlD
Pravastatin—Rash—Etoposide—brain cancer	0.000111	0.000878	CcSEcCtD
Pravastatin—Dermatitis—Etoposide—brain cancer	0.000111	0.000878	CcSEcCtD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000111	0.00458	CbGpPWpGaD
Pravastatin—Headache—Etoposide—brain cancer	0.00011	0.000873	CcSEcCtD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000107	0.00445	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000105	0.00436	CbGpPWpGaD
Pravastatin—Nausea—Etoposide—brain cancer	0.000105	0.000827	CcSEcCtD
Pravastatin—ABCB1—central nervous system—brain cancer	0.000102	0.00268	CbGeAlD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—S100A10—brain cancer	0.0001	0.00415	CbGpPWpGaD
Pravastatin—ABCB1—cerebellum—brain cancer	9.96e-05	0.00262	CbGeAlD
Pravastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	9.86e-05	0.00408	CbGpPWpGaD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—S100A10—brain cancer	9.82e-05	0.00407	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.79e-05	0.00405	CbGpPWpGaD
Pravastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	9.43e-05	0.0039	CbGpPWpGaD
Pravastatin—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	9.3e-05	0.00385	CbGpPWpGaD
Pravastatin—SLC22A7—Fluoropyrimidine Activity—TP53—brain cancer	9.26e-05	0.00383	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—S100A10—brain cancer	9.09e-05	0.00376	CbGpPWpGaD
Pravastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	8.79e-05	0.00364	CbGpPWpGaD
Pravastatin—CYP3A5—Biological oxidations—CYP2C9—brain cancer	8.73e-05	0.00361	CbGpPWpGaD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—S100A10—brain cancer	8.63e-05	0.00357	CbGpPWpGaD
Pravastatin—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	8.61e-05	0.00356	CbGpPWpGaD
Pravastatin—ABCB1—brain—brain cancer	8.09e-05	0.00213	CbGeAlD
Pravastatin—CYP3A4—Irinotecan Pathway—APC—brain cancer	8.01e-05	0.00331	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—BSG—brain cancer	8e-05	0.00331	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—CDK4—brain cancer	7.97e-05	0.0033	CbGpPWpGaD
Pravastatin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	7.64e-05	0.00316	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—S100A10—brain cancer	7.64e-05	0.00316	CbGpPWpGaD
Pravastatin—CYP2C8—Biological oxidations—CYP2C9—brain cancer	7.56e-05	0.00313	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.52e-05	0.00311	CbGpPWpGaD
Pravastatin—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	7.46e-05	0.00309	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.16e-05	0.00296	CbGpPWpGaD
Pravastatin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	7.1e-05	0.00294	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.08e-05	0.00293	CbGpPWpGaD
Pravastatin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	7.07e-05	0.00293	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	6.78e-05	0.00281	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	6.38e-05	0.00264	CbGpPWpGaD
Pravastatin—HMGCR—AMPK Signaling—TP53—brain cancer	6.35e-05	0.00263	CbGpPWpGaD
Pravastatin—CYP2D6—Biological oxidations—CYP2C9—brain cancer	6.21e-05	0.00257	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	6.18e-05	0.00256	CbGpPWpGaD
Pravastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	6.15e-05	0.00255	CbGpPWpGaD
Pravastatin—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	6.12e-05	0.00253	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.91e-05	0.00245	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	5.8e-05	0.0024	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.5e-05	0.00228	CbGpPWpGaD
Pravastatin—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	5.47e-05	0.00226	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	5.37e-05	0.00222	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—TRPC6—brain cancer	5.24e-05	0.00217	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.18e-05	0.00214	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—CCND1—brain cancer	5.15e-05	0.00213	CbGpPWpGaD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.11e-05	0.00211	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	5.1e-05	0.00211	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.06e-05	0.00209	CbGpPWpGaD
Pravastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	4.86e-05	0.00201	CbGpPWpGaD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—TRPC6—brain cancer	4.63e-05	0.00191	CbGpPWpGaD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—TRPC6—brain cancer	4.54e-05	0.00188	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	4.49e-05	0.00186	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—CYP2C9—brain cancer	4.36e-05	0.0018	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.32e-05	0.00179	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—PDGFRA—brain cancer	4.2e-05	0.00174	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—TRPC6—brain cancer	4.2e-05	0.00174	CbGpPWpGaD
Pravastatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	4.16e-05	0.00172	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—brain cancer	4.13e-05	0.00171	CbGpPWpGaD
Pravastatin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	4.06e-05	0.00168	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—brain cancer	4.04e-05	0.00167	CbGpPWpGaD
Pravastatin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	4e-05	0.00166	CbGpPWpGaD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—TRPC6—brain cancer	3.99e-05	0.00165	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—VAV1—brain cancer	3.93e-05	0.00162	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—CYP2C9—brain cancer	3.81e-05	0.00158	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—BSG—brain cancer	3.71e-05	0.00153	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.7e-05	0.00153	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—TRPC6—brain cancer	3.53e-05	0.00146	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	3.5e-05	0.00145	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—brain cancer	3.39e-05	0.0014	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—CYP2C9—brain cancer	3.35e-05	0.00139	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	3.32e-05	0.00137	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—BSG—brain cancer	3.24e-05	0.00134	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—IDH1—brain cancer	3.19e-05	0.00132	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—CYP2C9—brain cancer	3.15e-05	0.0013	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.13e-05	0.0013	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	2.94e-05	0.00122	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.9e-05	0.0012	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	2.9e-05	0.0012	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.85e-05	0.00118	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—BSG—brain cancer	2.85e-05	0.00118	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	2.8e-05	0.00116	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—IDH1—brain cancer	2.79e-05	0.00115	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—BSG—brain cancer	2.68e-05	0.00111	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.68e-05	0.00111	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—CYP2C9—brain cancer	2.63e-05	0.00109	CbGpPWpGaD
Pravastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	2.63e-05	0.00109	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.6e-05	0.00107	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—ENO2—brain cancer	2.52e-05	0.00104	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—PIK3CG—brain cancer	2.49e-05	0.00103	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.48e-05	0.00103	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—IDH1—brain cancer	2.45e-05	0.00101	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—IDH1—brain cancer	2.31e-05	0.000954	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.3e-05	0.000952	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—IL2—brain cancer	2.29e-05	0.000948	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.26e-05	0.000934	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—CYP2C9—brain cancer	2.25e-05	0.000932	CbGpPWpGaD
Pravastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.25e-05	0.00093	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—BSG—brain cancer	2.24e-05	0.000926	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.23e-05	0.000922	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—ENO2—brain cancer	2.2e-05	0.000912	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.12e-05	0.000879	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—CYP2C9—brain cancer	2.08e-05	0.000863	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.07e-05	0.000858	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.99e-05	0.000826	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.97e-05	0.000817	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.95e-05	0.000806	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—ENO2—brain cancer	1.94e-05	0.000801	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—IDH1—brain cancer	1.92e-05	0.000797	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—BSG—brain cancer	1.91e-05	0.000792	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.88e-05	0.000777	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—ENO2—brain cancer	1.82e-05	0.000754	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—BSG—brain cancer	1.77e-05	0.000733	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—IL2—brain cancer	1.75e-05	0.000726	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.73e-05	0.000715	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.71e-05	0.000706	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—IDH1—brain cancer	1.65e-05	0.000681	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.61e-05	0.000665	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.57e-05	0.000649	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—IDH1—brain cancer	1.52e-05	0.000631	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—ENO2—brain cancer	1.52e-05	0.00063	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CYP2C9—brain cancer	1.49e-05	0.000618	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—VEGFA—brain cancer	1.49e-05	0.000617	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.34e-05	0.000555	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.34e-05	0.000555	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—ENO2—brain cancer	1.3e-05	0.000538	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CYP2C9—brain cancer	1.29e-05	0.000535	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—BSG—brain cancer	1.27e-05	0.000526	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.25e-05	0.000516	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—ENO2—brain cancer	1.2e-05	0.000499	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—PIK3CG—brain cancer	1.16e-05	0.000479	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CYP2C9—brain cancer	1.13e-05	0.000466	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—TP53—brain cancer	1.13e-05	0.000466	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.1e-05	0.000456	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—BSG—brain cancer	1.1e-05	0.000455	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—IDH1—brain cancer	1.09e-05	0.000452	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.09e-05	0.000452	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CYP2C9—brain cancer	1.06e-05	0.000439	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—PIK3CG—brain cancer	1.01e-05	0.000418	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	9.61e-06	0.000398	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—BSG—brain cancer	9.58e-06	0.000397	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—IDH1—brain cancer	9.46e-06	0.000391	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—BSG—brain cancer	9.03e-06	0.000374	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—BSG—brain cancer	8.95e-06	0.00037	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PIK3CG—brain cancer	8.88e-06	0.000368	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	8.84e-06	0.000366	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	8.65e-06	0.000358	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—ENO2—brain cancer	8.63e-06	0.000357	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PIK3CG—brain cancer	8.36e-06	0.000346	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—IDH1—brain cancer	8.24e-06	0.000341	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—IDH1—brain cancer	7.77e-06	0.000321	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.7e-06	0.000319	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—IDH1—brain cancer	7.7e-06	0.000319	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ENO2—brain cancer	7.48e-06	0.000309	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	7.26e-06	0.0003	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PIK3CG—brain cancer	6.98e-06	0.000289	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CYP2C9—brain cancer	6.94e-06	0.000287	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ENO2—brain cancer	6.51e-06	0.00027	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.27e-06	0.000259	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ENO2—brain cancer	6.14e-06	0.000254	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ENO2—brain cancer	6.09e-06	0.000252	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PIK3CG—brain cancer	5.97e-06	0.000247	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—BSG—brain cancer	5.9e-06	0.000244	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PIK3CG—brain cancer	5.53e-06	0.000229	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—IDH1—brain cancer	5.08e-06	0.00021	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ENO2—brain cancer	4.01e-06	0.000166	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PIK3CG—brain cancer	3.96e-06	0.000164	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PIK3CG—brain cancer	3.43e-06	0.000142	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PIK3CG—brain cancer	2.99e-06	0.000124	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PIK3CG—brain cancer	2.82e-06	0.000117	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PIK3CG—brain cancer	2.79e-06	0.000116	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PIK3CG—brain cancer	1.84e-06	7.62e-05	CbGpPWpGaD
